Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) – Equities researchers at William Blair raised their Q4 2022 earnings per share estimates for shares of Henry Schein in a research report issued on Tuesday, August 2nd. William Blair analyst J. Kreger now forecasts that the company will post earnings of $1.22 per share for the quarter, up from their prior estimate of $1.17. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.85 per share.
Henry Schein (NASDAQ:HSIC – Get Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.16. The company had revenue of $3.03 billion during the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.11 EPS.
Henry Schein Trading Up 1.7 %
Shares of NASDAQ:HSIC opened at $75.38 on Friday. The stock has a 50 day moving average of $77.98 and a 200 day moving average of $81.97. The company has a current ratio of 1.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.18. Henry Schein has a 12-month low of $70.25 and a 12-month high of $92.68. The company has a market cap of $10.41 billion, a PE ratio of 16.18, a price-to-earnings-growth ratio of 2.01 and a beta of 0.75.
In other news, EVP Gerald A. Benjamin sold 11,489 shares of the business’s stock in a transaction that occurred on Thursday, May 26th. The stock was sold at an average price of $85.47, for a total transaction of $981,964.83. Following the transaction, the executive vice president now owns 95,616 shares of the company’s stock, valued at approximately $8,172,299.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.00% of the company’s stock.
Hedge Funds Weigh In On Henry Schein
Several hedge funds have recently bought and sold shares of HSIC. Covestor Ltd bought a new position in Henry Schein in the 4th quarter valued at $35,000. National Bank of Canada FI bought a new position in Henry Schein in the 4th quarter valued at $42,000. Venture Visionary Partners LLC bought a new position in Henry Schein in the 2nd quarter valued at $46,000. Quent Capital LLC bought a new position in Henry Schein in the 4th quarter valued at $47,000. Finally, Dupont Capital Management Corp grew its position in Henry Schein by 46.2% in the 1st quarter. Dupont Capital Management Corp now owns 611 shares of the company’s stock valued at $53,000 after acquiring an additional 193 shares during the last quarter. Institutional investors own 94.30% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Get a free copy of the StockNews.com research report on Henry Schein (HSIC)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.